LENOIR CITY, Tenn.,
Nov. 18, 2014 /PRNewswire/ --
Advanced Plasma Products, Inc. announced today that it has received
second year funding for an SBIR Phase II grant provided by the
National Institute of General Medical Sciences (NIGMS) of the
National Institutes of Health (NIH). The two year grant award total
is $2.2 million dollars.
Advanced Plasma Products, Inc. and its partners from the Center
for Biofilm Engineering at Montana State
University and the Graduate School of Medicine and the
College of Veterinary Medicine of The University of Tennessee are developing and testing
the Atmospheric Plasma Wound Applicator (APWA) device to treat
chronic wounds. The APWA is designed to eliminate biofilm
infection within a chronic wound and stimulate wound healing.
Chronic wounds are difficult to treat, generally take months or
years to heal and come at a high cost to patients and healthcare
providers. The global advanced wound care market is estimated to be
$20.5 billion by 2020. There are
approximately 50 million chronic wound cases reported annually, and
the incidence of chronic wounds is expected to rise with the steady
increase in adult and child obesity.
More information about the Atmospheric Plasma Wound Applicator
can be found on our website including a presentation by Dr.
Garth James, Director of the Medical
Biofilm Laboratory at the Center for Biofilm Engineering,
Montana State University. He
presented his findings at the recent Industrial Meeting at the
Center of Biofilm Engineering at Montana State
University, Bozeman, MT.
The company expects to complete testing of the AWPA in animal
models during the next six to nine months and has a goal of
starting limited human trials by the end of 2015.
Research reported in this press release was supported by the
National Institute of General Medical Sciences of the National
Institutes of Health under award number R44GM099207. The
content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institutes
of Health.
About Advanced Plasma Products, Inc.
Advanced Plasma
Products, Inc. is an engineering and applied research company with
expertise in developing atmospheric plasma products primarily
for the healthcare and agricultural sector. It is a wholly owned
subsidiary of Applied Science Products (OTC: APLD). More
information is available at our website, advancedplasmaproducts.com
or emailing info@advancedplasmaproducts.com .
Statements in this press release that are not historical
facts are forward-looking statements within the meaning of the
Securities Act of 1933, as amended. Those statements include
statements regarding the intent, belief or current expectations of
the Company and its management. Such statements reflect
management's current views, are based on certain assumptions and
involve risks and uncertainties. Actual results, events, or
performance may differ materially from the above forward-looking
statements due to a number of important factors, and will be
dependent upon a variety of factors, including, but not limited to,
the Company's ability to obtain additional financing, if and as
needed, and access funds from its existing financing arrangements
that will allow it to continue its current and future operations
and whether demand for its test products in domestic and
international markets will generate sufficient revenues to achieve
positive cash flow and profitability. The Company undertakes
no obligation to publicly update these forward-looking statements
to reflect events or circumstances that occur after the date hereof
or to reflect any change in the Company's expectations with regard
to these forward-looking statements or the occurrence of
unanticipated events.
SOURCE Advanced Plasma Products, Inc.